Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
about
LRRFIP1 Inhibits Hepatitis C Virus Replication by Inducing Type I Interferon in HepatocytesSynthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents.Identification and Characterization of Liver MicroRNAs of the Chinese Tree Shrew via Deep Sequencing.Management of hepatitis C genotype 4 in the directly acting antivirals era.An insight into the molecular characteristics of hepatitis C virus for clinicians.
P2860
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
@ast
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
@en
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
@nl
type
label
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
@ast
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
@en
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
@nl
prefLabel
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
@ast
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
@en
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
@nl
P2860
P3181
P356
P1476
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
@en
P2093
Warren Schmidt
Zeid Kayali
P2860
P304
P3181
P356
10.2147/PGPM.S52629
P407
P577
2014-01-01T00:00:00Z